Most Alternative Isoforms Are Not Functionally Important
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
There are two assertions that might be considered polemical in our Opinion article [1Tress M.L. et al.Alternative splicing may not be the key to proteome complexity.Trends Biochem. 2017; 42: 98-110Abstract Full Text Full Text PDF PubMed Scopus (174) Google Scholar]: the first is that most protein-coding genes have a single main isoform, and the second is that most annotated alternative transcripts do not generate functionally important gene products. While alternative isoforms can have important cellular roles, we believe that alternative splicing is not the key to proteome complexity. In his letter [2Blencowe B. The relationship between alternative splicing and proteomic complexity.Trends Biochem. 2017; 00 (000–000)Google Scholar] Professor Blencowe asks three rhetorical questions. The first is whether our results are surprising given the limitations of shotgun mass spectrometry (MS). Here Professor Blencowe can only be challenging the use of proteomics to support the existence of a single main protein isoform because our second assertion is not even partly based on the lack of proteomics evidence for alternative isoforms. The MS sensitivity argument is a red herring. MS experiments do support the existence of a single main isoform for most genes. These main isoforms coincide almost perfectly with dominant isoforms predicted from conservation of protein structural and functional features and with variants agreed upon by manual genome annotators [3Ezkurdia I. Most highly expressed protein-coding genes have a single dominant isoform.J. Proteome Res. 2015; 14: 1880-1887Crossref PubMed Scopus (66) Google Scholar]. By way of contrast, where RNA level studies do find dominant transcripts [4Gonzàlez-Porta M. Transcriptome analysis of human tissues and cell lines reveals one dominant transcript per gene.Genome Biol. 2013; 14: R70Crossref PubMed Scopus (159) Google Scholar], the overlap with the main proteomics isoform is remarkably low [3Ezkurdia I. Most highly expressed protein-coding genes have a single dominant isoform.J. Proteome Res. 2015; 14: 1880-1887Crossref PubMed Scopus (66) Google Scholar]. Part of the reason for this discrepancy is that RNA-seq transcript abundance algorithms are not good at estimating transcript abundance [5Hayer K.E. Benchmark analysis of algorithms for determining and quantifying full-length mRNA splice forms from RNA-seq data.Bioinformatics. 2015; 31: 3938-3945PubMed Google Scholar, 6Petryszak R. Expression Atlas update – an integrated database of gene and protein expression in humans, animals and plants.Nucleic Acids Res. 2016; 44: D746-D752Crossref PubMed Scopus (391) Google Scholar]. Question two is ‘are the conclusions justified based on the findings?’ In our opinion the available evidence leaves little room for doubt. Most protein coding genes have main protein isoforms, and most alternative exons are subject to neutral or near-neutral evolution (Box 1). We believe our conclusions are well substantiated and invite readers to judge for themselves in the article and related papers [3Ezkurdia I. Most highly expressed protein-coding genes have a single dominant isoform.J. Proteome Res. 2015; 14: 1880-1887Crossref PubMed Scopus (66) Google Scholar, 7Abascal F. Alternatively spliced homologous exons have ancient origins and are highly expressed at the protein level.PLoS Comput. Biol. 2015; 11: e1004325Crossref PubMed Scopus (46) Google Scholar].Box 1Most Alternative Exons Are Not Evolutionary Innovations.Professor Blencowe cites a 2006 review in support of his contention that most alternative variants are functionally important, even though they are known to be under relaxed selection pressure. This is clearly an oversight. In 2006 researchers calculated selection pressures by aligning human DNA sequences with the genomes of related species such as mouse. Many alternative exons were found to be poorly conserved between species, but some researchers interpreted this lack of conservation as lineage-specific innovations.A wealth of genome-wide genetic variation data from human populations has recently become available, enabling us to test whether alternative exons are undergoing purifying selection (whether they really are innovations). The variant data we analyzed were only available from 2012. These show that most alternative exons are evolving neutrally: they have a much higher non-synonymous to synonymous substitution ratio, and a 10-fold higher proportion of potentially damaging high-impact variants. Most interestingly, these figures do not decrease with increasing allele frequency, as would be expected if alternative exons were under selection pressure.The neutral or near-neutral selection pressures apparent in the current population are a very strong suggestion that most alternative variants have not been evolutionary selected to have important cellular roles. Professor Blencowe cites a 2006 review in support of his contention that most alternative variants are functionally im
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell type- and brain region-resolved mouse brain proteome
Sharma, K., Schmitt, S., Bergner, C. G., Tyanova, S., Kannaiyan, N., Manrique-Hoyos, N., Kongi, K., Cantuti, L., Hanisch, U.-K., Philips, M.-A., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4160 · Cited by 785
Ribosome Profiling Provides Evidence that Large Noncoding RNAs Do Not Encode Proteins
Guttman, M., Russell, P., Ingolia, N. T., Weissman, J. S., & Lander, E. S. (2013) · Cell · doi:10.1016/j.cell.2013.06.009 · Cited by 745 · cited 1×
“Previous studies have shown that non-coding transcripts are also routinely detected in ribosome profiling experiments and there is a healthy scepticism about whether these code for stable proteins [10, 11].”
BackgroundTranscriptome analysis of human tissues and cell lines reveals one dominant transcript per gene
Gonzàlez-Porta, M., Frankish, A., Rung, J., Harrow, J., & Brazma, A. (2013) · Genome Biology · doi:10.1186/gb-2013-14-7-r70 · Cited by 266
The Relationship between Alternative Splicing and Proteomic Complexity
Blencowe, B. J. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.04.001 · Cited by 178 · cited 2×
“The exon skipping events interrogated in the ribosome profiling experiment were overwhelmingly novel (more than 90% are not annotated in evidence-based genome annotations) [8], and a large proportion would lead to frame changes, as Professor Blencowe points out [2].”
BackgroundThe ribosome-engaged landscape of alternative splicing
Weatheritt, R. J., Sterne-Weiler, T., & Blencowe, B. J. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3317 · Cited by 162 · cited 2×
“Professor Blencowe’s ribosome profile experiments [8], while interesting, do not guarantee translation either.”
BackgroundHayer, K. E., Pizarro, A., Lahens, N. F., Hogenesch, J. B., & Grant, G. R. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv488 · Cited by 93
Cited by
The role of alternative splicing in cancer: From oncogenesis to drug resistance
Sciarrillo, R., Wojtuszkiewicz, A., Assaraf, Y. G., Jansen, G., Kaspers, G. J. L., Giovannetti, E., & Cloos, J. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100728 · Cited by 307
Impact of Alternative Splicing on the Human Proteome
Liu, Y., Gonzàlez-Porta, M., Santos, S., Brazma, A., Marioni, J. C., Aebersold, R., Venkitaraman, A. R., & Wickramasinghe, V. O. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.025 · Cited by 190
Wang, X., Codreanu, S. G., Wen, B., Li, K., Chambers, M. C., Liebler, D. C., & Zhang, B. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000155 · Cited by 97
Mudge, J. M., Jungreis, I., Hunt, T., Gonzalez, J. M., Wright, J. C., Kay, M., Davidson, C., Fitzgerald, S., Seal, R., Tweedie, S., et al. (2019) · Genome Research · doi:10.1101/gr.246462.118 · Cited by 80
“…the UniProt protein resource (The UniProt Consortium 2019), disagree on the number of human protein-coding genes (Abascal et al. 2018), and even when a gene is agreed to be protein coding, it is often unclear which transcripts within the locus are translated (Mudge et al. 2013; Tress et al. 2017).”
BackgroundSplice-Junction-Based Mapping of Alternative Isoforms in the Human Proteome
Lau, E., Han, Y., Williams, D. R., Thomas, C. T., Shrestha, R., Wu, J. C., & Lam, M. P. Y. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.026 · Cited by 67
Metadata
- Authors
- Tress, M. L., Abascal, F., & Valencia, A.
- Venue
- Trends in Biochemical Sciences
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 42
- Issue
- 6
- Pages
- 408-410
- ISSN
- 0968-0004 (ISSN-L)
- OpenAlex
- W2610621384
- Cited by
- 94
- References
- 6
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Most Alternative Isoforms Are Not Functionally Important. https://app.cochat.ai/papers/10.1016/j.tibs.2017.04.002
- The paper
- Tress, M. L., Abascal, F., & Valencia, A. (2017). Most Alternative Isoforms Are Not Functionally Important. Trends in Biochemical Sciences. https://doi.org/10.1016/j.tibs.2017.04.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.